Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 51
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

A knowledge-driven approach to extract disease-related biomarkers from the literature

  • Bravo Serrano, Àlex, 1984-
  • Cases, Montserrat
  • Queralt Rosinach, Núria
  • Sanz, Ferran
  • Furlong, Laura I., 1971-
The biomedical literature represents a rich source of biomarker information. However, both the size of literature databases and their lack of standardization hamper the automatic exploitation of the information contained in these resources. Text mining approaches have proven to be useful for the exploitation of information contained in the scientific publications. Here, we show that a knowledge-driven text mining approach can exploit a large literature database to extract a dataset of biomarkers related to diseases covering all therapeutic areas. Our methodology takes advantage of the annotation of MEDLINE publications pertaining to biomarkers with MeSH terms, narrowing the search to specific publications and, therefore, minimizing the false positive ratio. It is based on a dictionary-based named entity recognition system and a relation extraction module. The application of this methodology resulted in the identification of 131,012 disease-biomarker associations between 2,803 genes and 2,751 diseases, and represents a valuable knowledge base for those interested in disease-related biomarkers. Additionally, we present a bibliometric analysis of the journals reporting biomarker related information during the last 40 years., The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under Grants Agreements n°. [115002] (eTOX) and [115191] (Open PHACTS), resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007–2013) and EFPIA companies’ in kind contribution. À. Bravo and L. I. Furlong received support from Instituto de Salud Carlos III Fondo Europeo de Desarollo Regional (CP10/00524). The Research Programme on Biomedical Informatics (GRIB) is a node of the Spanish National Institute of Bioinformatics (INB).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

The eTOX data-sharing project to advance in Silico drug-induced toxicity prediction

  • Cases, Montserrat
  • Briggs, Katharine
  • Steger-Hartmann, Thomas
  • Pognan, François
  • Marc, Philippe
  • Kleinöder, Thomas
  • Schwab, Christof H.
  • Pastor Maeso, Manuel
  • Wichard, Jörg
  • Sanz, Ferran
The high-quality in vivo preclinical safety data produced by the pharmaceutical industry during drug development, which follows numerous strict guidelines, are mostly not available in the public domain. These safety data are sometimes published as a condensed summary for the few compounds that reach the market, but the majority of studies are never made public and are often difficult to access in an automated way, even sometimes within the owning company itself. It is evident from many academic and industrial examples, that useful data mining and model development requires large and representative data sets and careful curation of the collected data. In 2010, under the auspices of the Innovative Medicines Initiative, the eTOX project started with the objective of extracting and sharing preclinical study data from paper or pdf archives of toxicology departments of the 13 participating pharmaceutical companies and using such data for establishing a detailed, well-curated database, which could then serve as source for read-across approaches (early assessment of the potential toxicity of a drug candidate by comparison of similar structure and/or effects) and training of predictive models. The paper describes the efforts undertaken to allow effective data sharing intellectual property (IP) protection and set up of adequate controlled vocabularies) and to establish the database (currently with over 4000 studies contributed by the pharma companies corresponding to more than 1400 compounds). In addition, the status of predictive models building and some specific features of the eTOX predictive system (eTOXsys) are presented as decision support knowledge-based tools for drug development process at an early stage., The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115002 (eTOX), resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contributions. The authors would like to formally acknowledge the contribution to the eTOX project of all scientists and other staff involved
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Gene-disease network analysis reveals functional modules in mendelian, complex and environmental diseases

  • Mayer, Miguel Ángel, 1960-
  • Bundschus, Markus
  • Rautschka, Michael
  • Sanz, Ferran
  • Furlong, Laura I., 1971-
Abstract/nBACKGROUND: Scientists have been trying to understand the molecular mechanisms of diseases to design preventive and therapeutic strategies for a long time. For some diseases, it has become evident that it is not enough to obtain a catalogue of the disease-related genes but to uncover how disruptions of molecular networks in the cell give rise to disease phenotypes. Moreover, with the unprecedented wealth of information available, even obtaining such catalogue is extremely difficult./n/nPRINCIPAL FINDINGS: We developed a comprehensive gene-disease association database by integrating associations from several sources that cover different biomedical aspects of diseases. In particular, we focus on the current knowledge of human genetic diseases including mendelian, complex and environmental diseases. To assess the concept of modularity of human diseases, we performed a systematic study of the emergent properties of human gene-disease networks by means of network topology and functional annotation analysis. The results indicate a highly shared genetic origin of human diseases and show that for most diseases, including mendelian, complex and environmental diseases, functional modules exist. Moreover, a core set of biological pathways is found to be associated with most human diseases. We obtained similar results when studying clusters of diseases, suggesting that related diseases might arise due to dysfunction of common biological processes in the cell./n/nCONCLUSIONS: For the first time, we include mendelian, complex and environmental diseases in an integrated gene-disease association database and show that the concept of modularity applies for all of them. We furthermore provide a functional analysis of disease-related modules providing important new biological insights, which might not be discovered when considering each of the gene-disease association repositories independently. Hence, we present a suitable framework for the study of how genetic and environmental factors, such as drugs, contribute to diseases./n/nAVAILABILITY: The gene-disease networks used in this study and part of the analysis are available at http://ibi.imim.es/DisGeNET/DisGeNETweb.html#Download, This work was supported by the European Commission [EU-ADR, ICT-215847], Innovative Medicines Initiative [eTOX,115002], the AGAUR [to A.B.M.] and Instituto de Salud Carlos III FEDER (CP10/00524) grants
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Hepatotoxicity prediction by systems biology modeling of disturbed metabolic pathways using gene expression data

  • Carbonell, Pablo
  • López, Oriol
  • Amberg, Alexander
  • Pastor Maeso, Manuel
  • Sanz, Ferran
The present study applies a systems biology approach for the in silico predictive modeling of drug toxicity on the basis of high-quality preclinical drug toxicity data with the aim of increasing the mechanistic understanding of toxic effects of compounds at different levels (pathway, cell, tissue, organ). The model development was carried out using 77 compounds for which gene expression data for treated primary human hepatocytes is available in the LINCS database and for which rodent in vivo hepatotoxicity information is available in the eTOX database. The data from LINCS were used to determine the type and number of pathways disturbed by each compound and to estimate the extent of disturbance (network perturbation elasticity), and were used to analyze the correspondence with the in vivo information from eTOX. Predictive models were developed through this integrative analysis, and their specificity and sensitivity were assessed. The quality of the predictions was determined on the basis of the area under the curve (AUC) of plots of true positive vs. false positive rates (ROC curves). The ROC AUC reached values of up to 0.9 (out of 1.0) for some hepatotoxicity endpoints. Moreover, the most frequently disturbed metabolic pathways were determined across the studied toxicants. They included, e.g., mitochondrial beta-oxidation of fatty acids and amino acid metabolism. The process was exemplified by successful predictions on various statins. In conclusion, an entirely new approach linking gene expression alterations to the prediction of complex organ toxicity was developed and evaluated., The research leading to these results has received support from the Innovative Medicines Initiative (IMI) Joint Undertaking under grant agreement nº 115002 (eTOX), resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/200-2013) and EFPIA companie's in kind contributions.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

An automated tool for obtaining QSAR-ready series of compounds using semantic web technologies

  • López-Massaguer, Oriol
  • Sanz, Ferran
  • Pastor Maeso, Manuel
SUMMARY: We describe an application (Collector) for obtaining series of compounds annotated with bioactivity data, ready to be used for the development of quantitative structure-activity relationships (QSAR) models. The tool extracts data from the 'Open Pharmacological Space' (OPS) developed by the Open PHACTS project, using as input a valid name of the biological target. Collector uses the OPS ontologies for expanding the query using all known target synonyms and extracts compounds with bioactivity data against the target from multiple sources. The extracted data can be filtered to retain only drug-like compounds and the bioactivities can be automatically summarised to assign a single value per compound, yielding data ready to be used for QSAR modeling. The data obtained is locally stored facilitating the traceability and auditability of the process. Collector was used successfully for the development of models for toxicity endpoints within the eTOX project. AVAILABILITY AND IMPLEMENTATION: The software is available at http://phi.upf.edu/collector. The source code is located at https://github.com/phi-grib/Collector and is free for use under the GPL3 license. The web version is hosted at http://collector.upf.edu/. CONTACT: manuel.pastor@upf.edu. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online., This project was developed under the Innovative Medicines Initiative Joint Undertaking Open PHACTS Project, grant agreement number 115191 and eTOX project, grant agreement n° 115002, resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007–2013) and EFPIA companies’ in kind contributions
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Linear interaction energy based prediction of cytochrome P450 1A2 binding affinities with reliability estimation.

  • Capoferri, Luigi
  • Verkade-Vreeker, Marlies C. A.
  • Buitenhuis, Danny
  • Commandeu, Jan N.M.
  • Pastor Maeso, Manuel
  • Vermeulen, Nico P. E.
  • Geerke, Daan P.
Prediction of human Cytochrome P450 (CYP) binding affinities of small ligands, i.e., substrates and inhibitors, represents an important task for predicting drug-drug interactions. A quantitative assessment of the ligand binding affinity towards different CYPs can provide an estimate of inhibitory activity or an indication of isoforms prone to interact with the substrate of inhibitors. However, the accuracy of global quantitative models for CYP substrate binding or inhibition based on traditional molecular descriptors can be limited, because of the lack of information on the structure and flexibility of the catalytic site of CYPs. Here we describe the application of a method that combines protein-ligand docking, Molecular Dynamics (MD) simulations and Linear Interaction Energy (LIE) theory, to allow for quantitative CYP affinity prediction. Using this combined approach, a LIE model for human CYP 1A2 was developed and evaluated, based on a structurally diverse dataset for which the estimated experimental uncertainty was 3.3 kJ mol-1. For the computed CYP 1A2 binding affinities, the model showed a root mean square error (RMSE) of 4.1 kJ mol-1 and a standard error in prediction (SDEP) in cross-validation of 4.3 kJ mol-1. A novel approach that includes information on both structural ligand description and protein-ligand interaction was developed for estimating the reliability of predictions, and was able to identify compounds from an external test set with a SDEP for the predicted affinities of 4.6 kJ mol-1 (corresponding to 0.8 pKi units)., The work was supported by Innovative Medicines Initiative Joint Undertaking (IMI-JU) under grant agreement no. 115002 (eTOX), resources of which are composed of financial contribution from the European Union Seventh Framework Programme/n(FP7/20072013) and EFPIA companies in kind contribution; www.etoxproject.eu. The work was also supported by The Netherlands Organisation for Scientific Research (NWO, VIDI grant 723.012.105); www.nwo.nl.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Generating modeling data from repeat-dose toxicity reports

  • López Massaguer, Oriol, 1972-
  • Pinto Gil, Kevin
  • Sanz, Ferran
  • Amberg, Alexander
  • Anger, Lennart T.
  • Stolte, Manuela
  • Ravagli, Carlo
  • Marc, Philippe
  • Pastor Maeso, Manuel
Over the past decades, pharmaceutical companies have conducted a large number of high-quality in vivo repeat-dose toxicity (RDT) studies for regulatory purposes. As part of the eTOX project, a high number of these studies have been compiled and integrated into a database. This valuable resource can be queried directly, but it can be further exploited to build predictive models. As the studies were originally conducted to investigate the properties of individual compounds, the experimental conditions across the studies are highly heterogeneous. Consequently, the original data required normalization/standardization, filtering, categorization and integration to make possible any data analysis (such as building predictive models). Additionally, the primary objectives of the RDT studies were to identify toxicological findings, most of which do not directly translate to in vivo endpoints. This article describes a method to extract datasets containing comparable toxicological properties for a series of compounds amenable for building predictive models. The proposed strategy starts with the normalization of the terms used within the original reports. Then, comparable datasets are extracted from the database by applying filters based on the experimental conditions. Finally, carefully selected profiles of toxicological findings are mapped to endpoints of interest, generating QSAR-like tables. In this work, we describe in detail the strategy and tools used for carrying out these transformations and illustrate its application in a data sample extracted from the eTOX database. The suitability of the resulting tables for developing hazard-predicting models was investigated by building proof-of-concept models for in vivo liver endpoints., Innovative Medicines Initiative Joint Undertaking under grant agreement no. 115002 (eTOX), resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in-kind contributions. Innovative Medicines Initiative 2 Joint Undertaking under grant agreement no. 777365 (eTRANSAFE). This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA companies' in-kind contributions.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes.

  • Piñero González, Janet, 1977-
  • Queralt Rosinach, Núria
  • Bravo Serrano, Àlex, 1984-
  • Déu Pons, Jordi
  • Bauer-Mehren, Anna
  • Baron, Martin
  • Sanz, Ferran
  • Furlong, Laura I., 1971-
DisGeNET is a comprehensive discovery platform designed to address a variety of questions concerning the genetic underpinning of human diseases. DisGeNET contains over 380,000 associations between >16,000 genes and 13,000 diseases, which makes it one of the largest repositories currently available of its kind. DisGeNET integrates expert-curated databases with text-mined data, covers information on Mendelian and complex diseases, and includes data from animal disease models. It features a score based on the supporting evidence to prioritize gene-disease associations. It is an open access resource available through a web interface, a Cytoscape plugin and as a Semantic Web resource. The web interface supports user-friendly data exploration and navigation. DisGeNET data can also be analysed via the DisGeNET Cytoscape plugin, and enriched with the annotations of other plugins of this popular network analysis software suite. Finally, the information contained in DisGeNET can be expanded and complemented using Semantic Web technologies and linked to a variety of resources already present in the Linked Data cloud. Hence, DisGeNET offers one of the most comprehensive collections of human gene-disease associations and a valuable set of tools for investigating the molecular mechanisms underlying diseases of genetic origin, designed to fulfill the needs of different user profiles, including bioinformaticians, biologists and health-care practitioners. Database URL: http://www.disgenet.org/, This work was supported by Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (CP10/00524 and PI13/00082), the/nInnovative Medicines Initiative Joint Undertaking (115002 (eTOX), 115191 [Open PHACTS]), resources of which are composed of financial/ncontribution from the European Union’s Seventh Framework Programme [FP7/2007-2013] and EFPIA companies’ in kind contribution./nThe Research Programme on Biomedical Informatics (GRIB) is a node of the Spanish National Institute of Bioinformatics (INB). Funding for open access charge: Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (PI13/00082).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Mining the modular structure of protein interaction networks.

  • Berenstein, Ariel José
  • Piñero González, Janet, 1977-
  • Furlong, Laura I., 1971-
  • Chernomoretz, Ariel
BACKGROUND: Cluster-based descriptions of biological networks have received much attention in recent years fostered by accumulated evidence of the existence of meaningful correlations between topological network clusters and biological functional modules. Several well-performing clustering algorithms exist to infer topological network partitions. However, due to respective technical idiosyncrasies they might produce dissimilar modular decompositions of a given network. In this contribution, we aimed to analyze how alternative modular descriptions could condition the outcome of follow-up network biology analysis. METHODOLOGY: We considered a human protein interaction network and two paradigmatic cluster recognition algorithms, namely: the Clauset-Newman-Moore and the infomap procedures. We analyzed to what extent both methodologies yielded different results in terms of granularity and biological congruency. In addition, taking into account Guimera's cartographic role characterization of network nodes, we explored how the adoption of a given clustering methodology impinged on the ability to highlight relevant network meso-scale connectivity patterns. RESULTS: As a case study we considered a set of aging related proteins and showed that only the high-resolution modular description provided by infomap, could unveil statistically significant associations between them and inter/intra modular cartographic features. Besides reporting novel biological insights that could be gained from the discovered associations, our contribution warns against possible technical concerns that might affect the tools used to mine for interaction patterns in network biology studies. In particular our results suggested that sub-optimal partitions from the strict point of view of their modularity levels might still be worth being analyzed when meso-scale features were to be explored in connection with external source of biological knowledge., This project has been made possible by CONICET (grant PIP0087), UBACyT (grant 20020110200314), ISCIII-FEDER (PI13/00082 and CP10/00524), IMI JU (grant agreements n° [115002] (eTOX) and n° [115191] (Open PHACTS)], resources of which are composed of financial contribution from the EU's FP7 (FP7/2007–2013) and EFPIA companies’ in kind contribution)
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Toward a unifying strategy for the structure-based prediction of toxicological endpoints

  • Carrió Gaspar, Pau, 1982-
  • Sanz, Ferran
  • Pastor Maeso, Manuel
Most computational methods used for the prediction of toxicity endpoints are based on the assumption that similar compounds have similar biological properties. This principle can be exploited using computational methods like read across or quantitative structure-activity relationships. However, there is no general agreement about which method is the most appropriate for quantifying compound similarity neither for exploiting the similarity principle in order to obtain reliable estimations of the compound properties. Moreover, optimal similarity metrics and modeling methods might depend on the characteristics of the endpoints and training series used in each case. This study describes a comparative analysis of the predictive performance of diverse similarity metrics and modeling methods in toxicological applications. A collection of two quantitative (n = 660, n = 1114) and three qualitative (n = 447, n = 905, n = 1220) datasets representing very different endpoints of interest in drug safety evaluation and rigorous methods were used to estimate the external predictive ability in each case. The results confirm that no single approach produces the best results in all instances, and the best predictions were obtained using different tools in different situations. The trends observed in this study were exploited to propose a unifying strategy allowing the use of the most suitable method for every compound. A comparison of the quality of the predictions obtained by the unifying strategy with those obtained by standard prediction methods confirmed the usefulness of the proposed approach., The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking, under Grant Agreement No. 115002 (eTOX), resources of which are composed of a financial contribution from the European Union’s Seventh Framework Programme (FP7/2007–2013) and EFPIA companies’ in kind contributions
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Uncovering disease mechanisms through network biology in the era of next generation sequencing.

  • Piñero González, Janet, 1977-
  • Berenstein, Ariel José
  • González-Pérez, Abel
  • Chernomoretz, Ariel
  • Furlong, Laura I., 1971-
Characterizing the behavior of disease genes in the context of biological networks has the potential to shed light on disease mechanisms, and to reveal both new candidate disease genes and therapeutic targets. Previous studies addressing the network properties of disease genes have produced contradictory results. Here we have explored the causes of these discrepancies and assessed the relationship between the network roles of disease genes and their tolerance to deleterious germline variants in human populations leveraging on: the abundance of interactome resources, a comprehensive catalog of disease genes and exome variation data. We found that the most salient network features of disease genes are driven by cancer genes and that genes related to different types of diseases play network roles whose centrality is inversely correlated to their tolerance to likely deleterious germline mutations. This proved to be a multiscale signature, including global, mesoscopic and local network centrality features. Cancer driver genes, the most sensitive to deleterious variants, occupy the most central positions, followed by dominant disease genes and then by recessive disease genes, which are tolerant to variants and isolated within their network modules., We received support from UBACyT (20020130100582BA) and MinCyT (PICT2014-2701), ISCIII-FEDER (PI13/00082, CP10/00524), IMI-JU under grants agreements n° 115002 (eTOX), n° 115191 (Open PHACTS)], n° 115372 (EMIF) and n° 115735 (iPiE), resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution, and the EU H2020 Programme 2014-2020 under grant agreements no. 634143 (MedBioinformatics) and no. 676559 (Elixir-Excelerate). The Research Programme on Biomedical Informatics (GRIB) is a node of the Spanish National Institute of Bioinformatics (INB). A.G.-P. is supported by a Ramon y Cajal scholarship funded by the Spanish Ministry of Economy. The authors would like to thank the Exome Aggregation Consortium and the groups that provided exome variant data for comparison. A full list of contributing groups can be found at http://exac.broadinstitute.org/about.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Biana: a software framework for compiling biological interactions and analyzing networks

  • García-García, Javier, 1982-
  • Güney, Emre, 1983-
  • Aragüés Peleato, Ramón
  • Planas Iglesias, Joan, 1980-
  • Oliva Miguel, Baldomero
Background: The analysis and usage of biological data is hindered by the spread of information across multiple repositories and the difficulties posed by different nomenclature systems and storage formats. In particular, there is an important need for data unification in the study and use of protein-protein interactions. Without good integration strategies, it is difficult to analyze the whole set of available data and its properties./nResults: We introduce BIANA (Biologic Interactions and Network Analysis), a tool for biological information integration and network management. BIANA is a Python framework designed to achieve two major goals: i) the integration of multiple sources of biological information, including biological entities and their relationships, and ii) the management of biological information as a network where entities are nodes and relationships are edges. Moreover, BIANA uses properties of proteins and genes to infer latent biomolecular relationships by transferring edges to entities sharing similar properties. BIANA is also provided as a plugin for Cytoscape, which allows users to visualize and interactively manage the data. A web interface to BIANA providing basic functionalities is also available. The software can be downloaded under GNU GPL license from http://sbi.imim.es/web/BIANA.php./nConclusions: BIANA's approach to data unification solves many of the nomenclature issues common to systems dealing with biological data. BIANA can easily be extended to handle new specific data repositories and new specific data types. The unification protocol allows BIANA to be a flexible tool suitable for different user requirements: non-expert users can use a suggested unification protocol while expert users can define their own specific unification rules., JGG, EG and JPI are grateful to the support from “Departament d’Educació i Universitats de la Generalitat de Catalunya i del Fons Social Europeu”. BO also acknowledges support from BSC and Mare-Nostrum facilities. This work was supported by grants from Spanish Ministry of Science and Innovation (MICINN) BIO2008-0205, PSE-0100000-2007 and PSE-0100000-2009, and from EU grant Etox (IMI 115002)
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

A crowdsourcing workflow for extracting chemical-induced disease relations from free text.

  • Li, Tong Shu
  • Bravo Serrano, Àlex, 1984-
  • Furlong, Laura I., 1971-
  • Good, Benjamin M.
  • Su, Andrew I.
Relations between chemicals and diseases are one of the most queried biomedical interactions. Although expert manual curation is the standard method for extracting these relations from the literature, it is expensive and impractical to apply to large numbers of documents, and therefore alternative methods are required. We describe here a crowdsourcing workflow for extracting chemical-induced disease relations from free text as part of the BioCreative V Chemical Disease Relation challenge. Five non-expert workers on the CrowdFlower platform were shown each potential chemical-induced disease relation highlighted in the original source text and asked to make binary judgments about whether the text supported the relation. Worker responses were aggregated through voting, and relations receiving four or more votes were predicted as true. On the official evaluation dataset of 500 PubMed abstracts, the crowd attained a 0.505F-score (0.475 precision, 0.540 recall), with a maximum theoretical recall of 0.751 due to errors with named entity recognition. The total crowdsourcing cost was $1290.67 ($2.58 per abstract) and took a total of 7 h. A qualitative error analysis revealed that 46.66% of sampled errors were due to task limitations and gold standard errors, indicating that performance can still be improved. All code and results are publicly available athttps://github.com/SuLab/crowd_cid_relexDatabase, This work was supported by grants from the National Institutes of Health (GM114833, GM089820, TR001114); the Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (PI13/00082 and CP10/00524 to A.B. and L.I.F.); the Innovative Medicines Initiative-Joint Undertaking (eTOX No. 115002, Open PHACTs No. 115191, EMIF No. 115372, iPiE No. 115735 to A.B. and L.I.F.), resources of which are composed of financial contributions from the European Union’s Seventh Framework Programme (FP7/2007-2013) and European Federation of Pharmaceutical Industries and Associations; and the European Union Horizon 2020 Programme 2014–2020 (MedBioinformatics No. 634143 and Elixir-Excelerate No. 676559 to A.B. and L.I.F.). The Research Programme on Biomedical Informatics (GRIB) is a node of the Spanish National Institute of Bioinformatics (INB). Open access charges will be paid by grant number TR001114 from the National Institutes of Health.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

DisGeNET-RDF: harnessing the innovative power of the Semantic Web to explore the genetic basis of diseases.

  • Queralt Rosinach, Núria
  • Piñero González, Janet, 1977-
  • Bravo Serrano, Àlex, 1984-
  • Sanz, Ferran
  • Furlong, Laura I., 1971-
MOTIVATION: DisGeNET-RDF makes available knowledge on the genetic basis of human diseases in the Semantic Web. Gene-disease associations (GDAs) and their provenance metadata are published as human-readable and machine-processable web resources. The information on GDAs included in DisGeNET-RDF is interlinked to other biomedical databases to support the development of bioinformatics approaches for translational research through evidence-based exploitation of a rich and fully interconnected linked open data., We received support from ISCIII-FEDER (PI13/00082, CP10/00524), from the IMI-JU under grants agreements no. 115002 (eTOX), no. 115191 (Open PHACTS), no. 115372 (EMIF) and no. 115735 (iPiE), resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007–2013) and EFPIA companies’ in kind contribution, and the EU H2020 Programme 2014–2020 under grant agreements no. 634143 (MedBioinformatics) and no. 676559 (Elixir-Excelerate). The Research Programme on Biomedical Informatics (GRIB) is a node of the Spanish National Institute of Bioinformatics (INB).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Development of an infrastructure for the prediction of biological endpoints in industrial environments. Lessons learned at the eTOX Project

  • Pastor Maeso, Manuel
  • Quintana, Jordi
  • Sanz, Ferran
In silico methods are increasingly being used for assessing the chemical safety of substances, as a part of integrated approaches involving in vitro and in vivo experiments. A paradigmatic example of these strategies is the eTOX project http://www.etoxproject.eu, funded by the European Innovative Medicines Initiative (IMI), which aimed at producing high quality predictions of in vivo toxicity of drug candidates and resulted in generating about 200 models for diverse endpoints of toxicological interest. In an industry-oriented project like eTOX, apart from the predictive quality, the models need to meet other quality parameters related to the procedures for their generation and their intended use. For example, when the models are used for predicting the properties of drug candidates, the prediction system must guarantee the complete confidentiality of the compound structures. The interface of the system must be designed to provide non-expert users all the information required to choose the models and appropriately interpret the results. Moreover, procedures like installation, maintenance, documentation, validation and versioning, which are common in software development, must be also implemented for the models and for the prediction platform in which they are implemented. In this article we describe our experience in the eTOX project and the lessons learned after 7 years of close collaboration between industrial and academic partners. We believe that some of the solutions found and the tools developed could be useful for supporting similar initiatives in the future., The eTOX project (Grant Agreement No. 115002), was developed under the Innovative Medicines Initiative Joint Undertaking (IMI), resources of which are composed of a financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contributions. The authors of this article are also involved in other related IMI projects, such as iPiE (no. 115735), TransQST (no. 116030) and eTRANSAFE (no. 777365), as well as the H2020 EU-ToxRisk project (no. 681002)
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

eTOXlab, an open source modeling framework for implementing predictive models in production environments.

  • Carrió Gaspar, Pau, 1982-
  • López, Oriol
  • Sanz, Ferran
  • Pastor Maeso, Manuel
BACKGROUND: Computational models based in Quantitative-Structure Activity Relationship (QSAR) methodologies are widely used tools for predicting the biological properties of new compounds. In many instances, such models are used as a routine in the industry (e.g. food, cosmetic or pharmaceutical industry) for the early assessment of the biological properties of new compounds. However, most of the tools currently available for developing QSAR models are not well suited for supporting the whole QSAR model life cycle in production environments./nRESULTS: We have developed eTOXlab; an open source modeling framework designed to be used at the core of a self-contained virtual machine that can be easily deployed in production environments, providing predictions as web services. eTOXlab consists on a collection of object-oriented Python modules with methods mapping common tasks of standard modeling workflows. This framework allows building and validating QSAR models as well as predicting the properties of new compounds using either a command line interface or a graphic user interface (GUI). Simple models can be easily generated by setting a few parameters, while more complex models can be implemented by overriding pieces of the original source code. eTOXlab benefits from the object-oriented capabilities of Python for providing high flexibility: any model implemented using eTOXlab inherits the features implemented in the parent model, like common tools and services or the automatic exposure of the models as prediction web services. The particular eTOXlab architecture as a self-contained, portable prediction engine allows building models with confidential information within corporate facilities, which can be safely exported and used for prediction without disclosing the structures of the training series. CONCLUSIONS: The software presented here provides full support to the specific needs of users that want to develop, use and maintain predictive models in corporate environments. The technologies used by eTOXlab (web services, VM, object-oriented programming) provide an elegant solution to common practical issues; the system can be installed easily in heterogeneous environments and integrates well with other software. Moreover, the system provides a simple and safe solution for building models with confidential structures that can be shared without disclosing sensitive information, The research leading to these results has received support from the Innovative Medicines Initiative (IMI) Joint Undertaking under grant agreement n° 115002 (eTOX), resources of which are composed of financial contribution from the/nEuropean Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contributions
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

In Silico QT and APD prolongation assay for early screening of drug-induced proarrhythmic risk

  • Romero, Lucia
  • Cano, Jordi
  • Gomis-Tena, Julio
  • Trenor, Beatriz
  • Sanz, Ferran
  • Pastor Maeso, Manuel
  • Saiz, Javier
Drug-induced proarrhythmicity is a major concern for regulators and pharmaceutical companies. For novel drug candidates, the standard assessment involves the evaluation of the potassium hERG channels block and the in vivo prolongation of the QT interval. However, this method is known to be too restrictive and to stop the development of potentially valuable therapeutic drugs. The aim of this work is to create an in silico tool for early detection of drug-induced proarrhythmic risk. The system is based on simulations of how different compounds affect the action potential duration (APD) of isolated endocardial, midmyocardial, and epicardial cells as well as the QT prolongation in a virtual tissue. Multiple channel-drug interactions and state-of-the-art human ventricular action potential models ( O'Hara , T. , PLos Comput. Biol. 2011 , 7 , e1002061 ) were used in our simulations. Specifically, 206.766 cellular and 7072 tissue simulations were performed by blocking the slow and the fast components of the delayed rectifier current ( IKs and IKr, respectively) and the L-type calcium current ( ICaL) at different levels. The performance of our system was validated by classifying the proarrhythmic risk of 84 compounds, 40 of which present torsadogenic properties. On the basis of these results, we propose the use of a new index (Tx) for discriminating torsadogenic compounds, defined as the ratio of the drug concentrations producing 10% prolongation of the cellular endocardial, midmyocardial, and epicardial APDs and the QT interval, over the maximum effective free therapeutic plasma concentration (EFTPC). Our results show that the Tx index outperforms standard methods for early identification of torsadogenic compounds. Indeed, for the analyzed compounds, the Tx tests accuracy was in the range of 87-88% compared with a 73% accuracy of the hERG IC50 based test., L.R., J.C., J.G., B.T., J.S.: This work was partially supported by the Direccion General de Política Cientifíca de la Generalitat Valenciana (PROMETEU2016/088) as well as Ministerio de Economia y Competitividad and Fondo Europeo de Desarrollo Regional (FEDER) DPI2015-69125-R (MINECO/FEDER, UE). F.S, M.P.: received support from the Innovative Medicines Initiative (IMI) Joint Undertaking under grant agreement no. 115002 (eTOX), resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in-kind contributions
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Value of shared preclinical safety studies – The eTOX database

  • Briggs, Katharine
  • Barber, Chris
  • Cases, Montserrat
  • Marc, Philippe
  • Steger-Hartmann, Thomas
A first analysis of a database of shared preclinical safety data for 1214 small molecule drugs and drug candidates extracted from 3970 reports donated by thirteen pharmaceutical companies for the eTOX project (www.etoxproject.eu) is presented. Species, duration of exposure and administration route data were analysed to assess if large enough subsets of homogenous data are available for building in silico predictive models. Prevalence of treatment related effects for the different types of findings recorded were analysed. The eTOX ontology was used to determine the most common treatment-related clinical chemistry and histopathology findings reported in the database. The data were then mined to evaluate sensitivity of established in vivo biomarkers for liver toxicity risk assessment. The value of the database to inform other drug development projects during early drug development is illustrated by a case study., The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n°115002, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution. The authors would like to formally acknowledge the contribution to the eTOX project of all scientists and other staff involved.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

In Silico QT and APD Prolongation Assay for Early Screening of Drug-Induced Proarrhythmic Risk

  • Romero Pérez, Lucia|||0000-0003-4605-8630
  • Gomis-Tena Dolz, Julio|||0000-0002-1309-2368
  • Saiz Rodríguez, Francisco Javier|||0000-0002-9850-0825
  • Cano-García, Jordi
  • Trenor Gomis, Beatriz Ana
  • Sanz, Ferran
  • Pastor, Manuel
[EN] Drug-induced proarrhythmicity is a major concern for regulators and pharmaceutical companies. For novel drug candidates, the standard assessment involves the evaluation of the potassium hERG channels block and the in vivo prolongation of the QT interval. However, this method is known to be too restrictive and to stop the development of potentially valuable therapeutic drugs. The aim of this work is to create an in silico tool for early detection of drug-induced proarrhythmic risk. The system is based on simulations of how different compounds affect the action potential duration (APD) of isolated endocardial, midmyocardial, and epicardial cells as well as the QT prolongation in a virtual tissue. Multiple channel-drug interactions and state-of-the-art human ventricular action potential models (O'Hara, T., et al. PLos Comput. Biol. 2011, 7, e1002061) were used in our simulations. Specifically, 206.766 cellular and 7072 tissue simulations were performed by blocking the slow and the fast components of the delayed rectifier current (I-Ks and I-Kr, respectively) and the L-type calcium current (I-CaL) at different levels. The performance of our system was validated by classifying the proarrhythmic risk of 84 compounds, 40 of which present torsadogenic properties. On the basis of these results, we propose the use of a new index (Tx) for discriminating torsadogenic compounds, defined as the ratio of the drug concentrations producing 10% prolongation of the cellular endocardial, midmyocardial, and epicardial APDs and the QT interval, over the maximum effective free therapeutic plasma concentration (EFTPC). Our results show that the Tx index outperforms standard methods for early identification of torsadogenic compounds. Indeed, for the analyzed compounds, the Tx tests accuracy was in the range of 87-88% compared with a 73% accuracy of the hERG IC50 based test., L.R, J.C., J.G., B.T., J.S.: This work was partially supported by the Direccion General de Politica Cientifica de la Generalitat Valenciana (PROMETEU2016/088) as well as Ministerio de Economia y Competitividad and Fondo Europeo de Desarrollo Regional (FEDER) DPI2015-69125-R (MINECO/FEDER, UE). F.S, M.P.: received support from the Innovative Medicines Initiative (IMI) Joint Undertaking under grant agreement no. 115002 (eTOX), resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in-kind contributions.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Datos de investigación Set de datos (Dataset)

APD, QT interval and Tx Values

  • Saiz Rodríguez, Francisco Javier|||0000-0002-9850-0825
  • Trenor Gomis, Beatriz Ana|||0000-0001-9166-6112
  • Gomis-Tena Dolz, Julio|||0000-0002-1309-2368
  • Romero Pérez, Lucia|||0000-0003-4605-8630
  • Sanz i Carreras, Ferran
  • Pastor Maeso, Manuel
  • Cano García, Jordi
This repository contains four Excel 2017 files named “APD.xlsx”, “QT.xlsx”, “Tx_APD.xlsx” and “Tx_QT.xlsx”. APD.xlsx and Tx_APD.xlsx files contain three sheets (called “Epi”, “Mid” and “Endo”), whereas the rest contain only one sheet (called “QT”). These files contain the results of simulations performed in the O’Hara-Rudy model (ORd) [1] of human ventricular cells (206.766 simulations) and tissue (7072 simulations), which consist of APD90 and QT intervals as well as a new index called Tx extracted from both APD and QT values. References: [1]. O’Hara, T.; Virág, L.; Varró, A.; Rudy, Y. Simulation of the Undiseased Human Cardiac Ventricular Action Potential: Model Formulation and Experimental Validation. PLoS Comput. Biol. 2011, 7 (5), e1002061. [2]. Romero L., Cano J., Gomis-Tena J., Trenor B., Sanz F., Pastor M., Saiz J. In silico QT and APD Prolongation Assay for Early Screening of Drug-Induced Proarrhythmic Risk. Journal of Chemical Information and Modeling. 2017 (Currently in revision).
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

BPC transcription factors and a Polycomb Group protein confine the expression of the ovule identity gene SEEDSTICK in Arabidopsis

  • Petrella, Rosanna
  • Caselli, Francesca
  • Roig Villanova, Irma|||0000-0001-9124-0429
  • Vignati, Valentina
  • Chiara, Matteo
  • Ezquer, Ignacio
  • Tadini, Luca
  • Kater, Martin M.
  • Gregis, Veronica
The BASIC PENTACYSTEINE (BPC) GAGA (C-box) binding proteins belong to a small plant transcription factor family. We previously reported that BPCs of class I bind directly to C-boxes in the SEEDSTICK (STK) promoter and the mutagenesis of these cis-elements affects STK expression in the flower. The MADS-domain factor SHORT VEGETATIVE PHASE (SVP) is another key regulator of STK. Direct binding of SVP to CArG-boxes in the STK promoter are required to repress its expression during the first stages of flower development
UPCommons. Portal del coneixement obert de la UPC
Publicación Contribución de congreso (ConferenceOutput)

A first look into Alexa’s interaction security

  • Castell Uroz, Ismael
  • Marrugat Plaza, Xavier
  • Solé Pareta, Josep|||0000-0002-9411-6308
  • Barlet Ros, Pere|||0000-0001-7837-0886
With a rapidly increasing market of millions of devices, the intelligent virtual assistants (IVA) have become a new vector available to exploit security breaches. In this work we approach the third revision of the Amazon Echo ecosystem's device Alexa from a security perspective, focusing our efforts on the interaction between the user and the device. We found the client-server communications to be robust using encryption, but studying the voice message recognition system we discovered a method to execute voice commands remotely, a feature not available by default. This method could be used against the user if an attacker manages to perform a session hijacking attack on the web or mobile clients., This work was supported by the Spanish MINECO under contractTEC2017-90034-C2-1-R (ALLIANCE), Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

LimTox: a web tool for applied text mining of adverse event and toxicity associations of compounds, drugs and genes

  • Cañada, Andres
  • Capella-Gutierrez, Salvador
  • Rabal, Obdulia
  • Oyarzabal, Julen
  • Valencia, Alfonso|||0000-0002-8937-6789
  • Krallinger, Martin
A considerable effort has been devoted to retrieve systematically information for genes and proteins as well as relationships between them. Despite the importance of chemical compounds and drugs as a central bio-entity in pharmacological and biological research, only a limited number of freely available chemical text-mining/search engine technologies are currently accessible. Here we present LimTox (Literature Mining for Toxicology), a web-based online biomedical search tool with special focus on adverse hepatobiliary reactions. It integrates a range of text mining, named entity recognition and information extraction components. LimTox relies on machine-learning, rule-based, pattern-based and term lookup strategies. This system processes scientific abstracts, a set of full text articles and medical agency assessment reports. Although the main focus of LimTox is on adverse liver events, it enables also basic searches for other organ level toxicity associations (nephrotoxicity, cardiotoxicity, thyrotoxicity and phospholipidosis). This tool supports specialized search queries for: chemical compounds/drugs, genes (with additional emphasis on key enzymes in drug metabolism, namely P450 cytochromes—CYPs) and biochemical liver markers. The LimTox website is free and open to all users and there is no login requirement. LimTox can be accessed at: http://limtox.bioinfo.cnio.es, eTOX project [IMI-115002]; European Commission H2020 project OpenMinted [654021]; Plan de Impulso de las Tecnologías del Lenguaje de la Agenda Digital (PITL) of the Secretary of State of Telecommunications of the Spanish Ministry of Energy, Tourism and the Digital Agenda; ISCIII and ERDF [PT13/0001/00]. Funding for open access charge: European Commission H2020 project Open-Minted [654021]., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Sliding modes in a class of complex-valued nonlinear systems

  • Dòria Cerezo, Arnau|||0000-0001-9352-066X
  • Olm Miras, Josep Maria|||0000-0003-4925-9251
  • Biel Solé, Domingo|||0000-0002-0364-7681
  • Fossas Colet, Enric|||0000-0002-3589-6092
© 2021 IEEE. Personal use of this material is permitted. Permission from IEEE must be obtained for all other uses, in any current or future media, including reprinting /republishing this material for advertising or promotional purposes, creating new collective works, for resale or redistribution to servers or lists, or reuse of any copyrighted component of this work in other works, A number of physical systems allow a complex-valued representation. This article extends the theory of sliding modes to a class of nonlinear systems described by complex-valued variables. Hence, states, parameters, control actions, and sliding manifolds belong, in general, to the complex field. In this article, it is also shown that the proposed design in the complex-valued framework provides shorter reaching times to the sliding manifold than the standard sliding-mode design at equal initial condition and control effort. Different implementation approaches are also evaluated, and numerical examples illustrate the proposal., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Contribución de congreso (ConferenceOutput)

People's V-formation and side-by-side model adapted to accompany groups of people by social robots

  • Repiso Polo, Ely|||0000-0001-6540-8347
  • Zanlungo, Francesco
  • Kanda, Takayuki
  • Garrell Zulueta, Anais|||0000-0002-4629-0723
  • Sanfeliu Cortés, Alberto|||0000-0003-3868-9678
© 2019 IEEE. Personal use of this material is permitted. Permission from IEEE must be obtained for all other uses, in any current or future media, including reprinting/republishing this material for advertising or promotional purposes, creating new collective works, for resale or redistribution to servers or lists, or reuse of any copyrighted component of this work in other works., This paper presents a new method to allow robots to accompany a person or a group of people imitating pedestrians behavior. Two-people groups usually walk in a side-by-side formation and three-people groups walk in a V-formation so that they can see each other. For this reason, the proposed method combines a Side-by-side and V-formation pedestrian model with the Anticipative Kinodynamic Planner (AKP). Combining these methods, the robot is able to do an anticipatory accompaniment of groups of humans, as well as to avoid static and dynamic obstacles in advance, while keeping the prescribed formations. The proposed framework allows also a dynamical re-positioning of the robot, if the physical position of the partners change in the group formation. Furthermore, people have a randomness factor that the robot has to manage, for that reason, the system was adapted to deal with changes in people's velocity, orientation and occlusions. Finally, the method has been validated using synthetic experiments and real-life experiments with our Tibi robot. In addition, a user study has been realized to reveal the social acceptability of the method., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Impact of sea-level rise on the tourist-carrying capacity of Catalan beaches

  • López-Doriga Sandoval, Uxía|||0000-0002-9236-683X
  • Jiménez Quintana, José Antonio|||0000-0003-0900-4684
  • Valdemoro Garcia, Herminia
  • Nicholls, Robert J.
Tourism provides about 11% of Catalonia's GDP, with most accommodations placed being associated with the “sun-and-sand” model. Since beaches are the main resource to be exploited, it is important to assess how their future evolution can affect this economic sector. Accordingly, we present a methodology to assess the effect of shoreline evolution on beach recreational carrying capacity (BCC) at different territorial scales considering different climate change scenarios. Our results suggest that by 2050, in the absence of climate change, tourist BCC will decrease down to 83% of current values due to the dominant erosive behaviour of the Catalan coast. When sea-level rise is considered, BCC will decrease further, with expected values ranging from 74% to 53% of current capacity for the tested scenarios (RCP4.5 and High-end respectively). Hence, current erosional trends are adverse for future development of coastal tourism in Catalonia, and accelerated sea-level rise exacerbates this adverse situation. The adopted methodology permits to locate hotspots along the territory where local BCC values collapse as well as to predict when this will occur under a given climatic scenario. Moreover, the use of different spatial scales to integrate BCC permits to test management strategies to sustaining the recreational use of beaches., Peer Reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Impact of sea-level rise on the tourist-carrying capacity of Catalan beaches

  • López-Doriga Sandoval, Uxía
  • Jiménez Quintana, José Antonio
  • Valdemoro Garcia, Herminia
  • Nicholls, Robert J.
Tourism provides about 11% of Catalonia's GDP, with most accommodations placed being associated with the “sun-and-sand” model. Since beaches are the main resource to be exploited, it is important to assess how their future evolution can affect this economic sector. Accordingly, we present a methodology to assess the effect of shoreline evolution on beach recreational carrying capacity (BCC) at different territorial scales considering different climate change scenarios. Our results suggest that by 2050, in the absence of climate change, tourist BCC will decrease down to 83% of current values due to the dominant erosive behaviour of the Catalan coast. When sea-level rise is considered, BCC will decrease further, with expected values ranging from 74% to 53% of current capacity for the tested scenarios (RCP4.5 and High-end respectively). Hence, current erosional trends are adverse for future development of coastal tourism in Catalonia, and accelerated sea-level rise exacerbates this adverse situation. The adopted methodology permits to locate hotspots along the territory where local BCC values collapse as well as to predict when this will occur under a given climatic scenario. Moreover, the use of different spatial scales to integrate BCC permits to test management strategies to sustaining the recreational use of beaches., Peer Reviewed, Postprint (author's final draft)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Sliding modes in a class of complex-valued nonlinear systems

  • Dòria Cerezo, Arnau
  • Olm Miras, Josep Maria
  • Biel Solé, Domingo
  • Fossas Colet, Enric
© 2021 IEEE. Personal use of this material is permitted. Permission from IEEE must be obtained for all other uses, in any current or future media, including reprinting /republishing this material for advertising or promotional purposes, creating new collective works, for resale or redistribution to servers or lists, or reuse of any copyrighted component of this work in other works, A number of physical systems allow a complex-valued representation. This article extends the theory of sliding modes to a class of nonlinear systems described by complex-valued variables. Hence, states, parameters, control actions, and sliding manifolds belong, in general, to the complex field. In this article, it is also shown that the proposed design in the complex-valued framework provides shorter reaching times to the sliding manifold than the standard sliding-mode design at equal initial condition and control effort. Different implementation approaches are also evaluated, and numerical examples illustrate the proposal., Peer Reviewed, Postprint (author's final draft)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Linear interaction energy based prediction of cytochrome P450 1A2 binding affinities with reliability estimation.

  • Capoferri, Luigi
  • Verkade-Vreeker, Marlies C. A.
  • Buitenhuis, Danny
  • Commandeu, Jan N.M.
  • Pastor Maeso, Manuel
  • Vermeulen, Nico P. E.
  • Geerke, Daan P.
Prediction of human Cytochrome P450 (CYP) binding affinities of small ligands, i.e., substrates and inhibitors, represents an important task for predicting drug-drug interactions. A quantitative assessment of the ligand binding affinity towards different CYPs can provide an estimate of inhibitory activity or an indication of isoforms prone to interact with the substrate of inhibitors. However, the accuracy of global quantitative models for CYP substrate binding or inhibition based on traditional molecular descriptors can be limited, because of the lack of information on the structure and flexibility of the catalytic site of CYPs. Here we describe the application of a method that combines protein-ligand docking, Molecular Dynamics (MD) simulations and Linear Interaction Energy (LIE) theory, to allow for quantitative CYP affinity prediction. Using this combined approach, a LIE model for human CYP 1A2 was developed and evaluated, based on a structurally diverse dataset for which the estimated experimental uncertainty was 3.3 kJ mol-1. For the computed CYP 1A2 binding affinities, the model showed a root mean square error (RMSE) of 4.1 kJ mol-1 and a standard error in prediction (SDEP) in cross-validation of 4.3 kJ mol-1. A novel approach that includes information on both structural ligand description and protein-ligand interaction was developed for estimating the reliability of predictions, and was able to identify compounds from an external test set with a SDEP for the predicted affinities of 4.6 kJ mol-1 (corresponding to 0.8 pKi units)., The work was supported by Innovative Medicines Initiative Joint Undertaking (IMI-JU) under grant agreement no. 115002 (eTOX), resources of which are composed of financial contribution from the European Union Seventh Framework Programme/n(FP7/20072013) and EFPIA companies in kind contribution; www.etoxproject.eu. The work was also supported by The Netherlands Organisation for Scientific Research (NWO, VIDI grant 723.012.105); www.nwo.nl.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A knowledge-driven approach to extract disease-related biomarkers from the literature

  • Bravo Serrano, Àlex, 1984-
  • Cases, Montserrat
  • Queralt Rosinach, Núria
  • Sanz, Ferran
  • Furlong, Laura I., 1971-
The biomedical literature represents a rich source of biomarker information. However, both the size of literature databases and their lack of standardization hamper the automatic exploitation of the information contained in these resources. Text mining approaches have proven to be useful for the exploitation of information contained in the scientific publications. Here, we show that a knowledge-driven text mining approach can exploit a large literature database to extract a dataset of biomarkers related to diseases covering all therapeutic areas. Our methodology takes advantage of the annotation of MEDLINE publications pertaining to biomarkers with MeSH terms, narrowing the search to specific publications and, therefore, minimizing the false positive ratio. It is based on a dictionary-based named entity recognition system and a relation extraction module. The application of this methodology resulted in the identification of 131,012 disease-biomarker associations between 2,803 genes and 2,751 diseases, and represents a valuable knowledge base for those interested in disease-related biomarkers. Additionally, we present a bibliometric analysis of the journals reporting biomarker related information during the last 40 years., The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under Grants Agreements n°. [115002] (eTOX) and [115191] (Open PHACTS), resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007–2013) and EFPIA companies’ in kind contribution. À. Bravo and L. I. Furlong received support from Instituto de Salud Carlos III Fondo Europeo de Desarollo Regional (CP10/00524). The Research Programme on Biomedical Informatics (GRIB) is a node of the Spanish National Institute of Bioinformatics (INB).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Development of an infrastructure for the prediction of biological endpoints in industrial environments. Lessons learned at the eTOX Project

  • Pastor Maeso, Manuel
  • Quintana, Jordi
  • Sanz, Ferran
In silico methods are increasingly being used for assessing the chemical safety of substances, as a part of integrated approaches involving in vitro and in vivo experiments. A paradigmatic example of these strategies is the eTOX project http://www.etoxproject.eu, funded by the European Innovative Medicines Initiative (IMI), which aimed at producing high quality predictions of in vivo toxicity of drug candidates and resulted in generating about 200 models for diverse endpoints of toxicological interest. In an industry-oriented project like eTOX, apart from the predictive quality, the models need to meet other quality parameters related to the procedures for their generation and their intended use. For example, when the models are used for predicting the properties of drug candidates, the prediction system must guarantee the complete confidentiality of the compound structures. The interface of the system must be designed to provide non-expert users all the information required to choose the models and appropriately interpret the results. Moreover, procedures like installation, maintenance, documentation, validation and versioning, which are common in software development, must be also implemented for the models and for the prediction platform in which they are implemented. In this article we describe our experience in the eTOX project and the lessons learned after 7 years of close collaboration between industrial and academic partners. We believe that some of the solutions found and the tools developed could be useful for supporting similar initiatives in the future., The eTOX project (Grant Agreement No. 115002), was developed under the Innovative Medicines Initiative Joint Undertaking (IMI), resources of which are composed of a financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contributions. The authors of this article are also involved in other related IMI projects, such as iPiE (no. 115735), TransQST (no. 116030) and eTRANSAFE (no. 777365), as well as the H2020 EU-ToxRisk project (no. 681002)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Toward a unifying strategy for the structure-based prediction of toxicological endpoints

  • Carrió Gaspar, Pau, 1982-
  • Sanz, Ferran
  • Pastor Maeso, Manuel
Most computational methods used for the prediction of toxicity endpoints are based on the assumption that similar compounds have similar biological properties. This principle can be exploited using computational methods like read across or quantitative structure-activity relationships. However, there is no general agreement about which method is the most appropriate for quantifying compound similarity neither for exploiting the similarity principle in order to obtain reliable estimations of the compound properties. Moreover, optimal similarity metrics and modeling methods might depend on the characteristics of the endpoints and training series used in each case. This study describes a comparative analysis of the predictive performance of diverse similarity metrics and modeling methods in toxicological applications. A collection of two quantitative (n = 660, n = 1114) and three qualitative (n = 447, n = 905, n = 1220) datasets representing very different endpoints of interest in drug safety evaluation and rigorous methods were used to estimate the external predictive ability in each case. The results confirm that no single approach produces the best results in all instances, and the best predictions were obtained using different tools in different situations. The trends observed in this study were exploited to propose a unifying strategy allowing the use of the most suitable method for every compound. A comparison of the quality of the predictions obtained by the unifying strategy with those obtained by standard prediction methods confirmed the usefulness of the proposed approach., The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking, under Grant Agreement No. 115002 (eTOX), resources of which are composed of a financial contribution from the European Union’s Seventh Framework Programme (FP7/2007–2013) and EFPIA companies’ in kind contributions
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The eTOX data-sharing project to advance in Silico drug-induced toxicity prediction

  • Cases, Montserrat
  • Briggs, Katharine
  • Steger-Hartmann, Thomas
  • Pognan, François
  • Marc, Philippe
  • Kleinöder, Thomas
  • Schwab, Christof H.
  • Pastor Maeso, Manuel
  • Wichard, Jörg
  • Sanz, Ferran
The high-quality in vivo preclinical safety data produced by the pharmaceutical industry during drug development, which follows numerous strict guidelines, are mostly not available in the public domain. These safety data are sometimes published as a condensed summary for the few compounds that reach the market, but the majority of studies are never made public and are often difficult to access in an automated way, even sometimes within the owning company itself. It is evident from many academic and industrial examples, that useful data mining and model development requires large and representative data sets and careful curation of the collected data. In 2010, under the auspices of the Innovative Medicines Initiative, the eTOX project started with the objective of extracting and sharing preclinical study data from paper or pdf archives of toxicology departments of the 13 participating pharmaceutical companies and using such data for establishing a detailed, well-curated database, which could then serve as source for read-across approaches (early assessment of the potential toxicity of a drug candidate by comparison of similar structure and/or effects) and training of predictive models. The paper describes the efforts undertaken to allow effective data sharing intellectual property (IP) protection and set up of adequate controlled vocabularies) and to establish the database (currently with over 4000 studies contributed by the pharma companies corresponding to more than 1400 compounds). In addition, the status of predictive models building and some specific features of the eTOX predictive system (eTOXsys) are presented as decision support knowledge-based tools for drug development process at an early stage., The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115002 (eTOX), resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contributions. The authors would like to formally acknowledge the contribution to the eTOX project of all scientists and other staff involved
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Generating modeling data from repeat-dose toxicity reports

  • López Massaguer, Oriol, 1972-
  • Pinto Gil, Kevin
  • Sanz, Ferran
  • Amberg, Alexander
  • Anger, Lennart T.
  • Stolte, Manuela
  • Ravagli, Carlo
  • Marc, Philippe
  • Pastor Maeso, Manuel
Over the past decades, pharmaceutical companies have conducted a large number of high-quality in vivo repeat-dose toxicity (RDT) studies for regulatory purposes. As part of the eTOX project, a high number of these studies have been compiled and integrated into a database. This valuable resource can be queried directly, but it can be further exploited to build predictive models. As the studies were originally conducted to investigate the properties of individual compounds, the experimental conditions across the studies are highly heterogeneous. Consequently, the original data required normalization/standardization, filtering, categorization and integration to make possible any data analysis (such as building predictive models). Additionally, the primary objectives of the RDT studies were to identify toxicological findings, most of which do not directly translate to in vivo endpoints. This article describes a method to extract datasets containing comparable toxicological properties for a series of compounds amenable for building predictive models. The proposed strategy starts with the normalization of the terms used within the original reports. Then, comparable datasets are extracted from the database by applying filters based on the experimental conditions. Finally, carefully selected profiles of toxicological findings are mapped to endpoints of interest, generating QSAR-like tables. In this work, we describe in detail the strategy and tools used for carrying out these transformations and illustrate its application in a data sample extracted from the eTOX database. The suitability of the resulting tables for developing hazard-predicting models was investigated by building proof-of-concept models for in vivo liver endpoints., Innovative Medicines Initiative Joint Undertaking under grant agreement no. 115002 (eTOX), resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in-kind contributions. Innovative Medicines Initiative 2 Joint Undertaking under grant agreement no. 777365 (eTRANSAFE). This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA companies' in-kind contributions.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Contribución de congreso (ConferenceOutput)

People's V-formation and side-by-side model adapted to accompany groups of people by social robots

  • Repiso Polo, Ely
  • Zanlungo, Francesco
  • Kanda, Takayuki
  • Garrell Zulueta, Anais
  • Sanfeliu Cortés, Alberto
© 2019 IEEE. Personal use of this material is permitted. Permission from IEEE must be obtained for all other uses, in any current or future media, including reprinting/republishing this material for advertising or promotional purposes, creating new collective works, for resale or redistribution to servers or lists, or reuse of any copyrighted component of this work in other works., This paper presents a new method to allow robots to accompany a person or a group of people imitating pedestrians behavior. Two-people groups usually walk in a side-by-side formation and three-people groups walk in a V-formation so that they can see each other. For this reason, the proposed method combines a Side-by-side and V-formation pedestrian model with the Anticipative Kinodynamic Planner (AKP). Combining these methods, the robot is able to do an anticipatory accompaniment of groups of humans, as well as to avoid static and dynamic obstacles in advance, while keeping the prescribed formations. The proposed framework allows also a dynamical re-positioning of the robot, if the physical position of the partners change in the group formation. Furthermore, people have a randomness factor that the robot has to manage, for that reason, the system was adapted to deal with changes in people's velocity, orientation and occlusions. Finally, the method has been validated using synthetic experiments and real-life experiments with our Tibi robot. In addition, a user study has been realized to reveal the social acceptability of the method., Peer Reviewed, Postprint (author's final draft)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Value of shared preclinical safety studies – The eTOX database

  • Briggs, Katharine
  • Barber, Chris
  • Cases, Montserrat
  • Marc, Philippe
  • Steger-Hartmann, Thomas
A first analysis of a database of shared preclinical safety data for 1214 small molecule drugs and drug candidates extracted from 3970 reports donated by thirteen pharmaceutical companies for the eTOX project (www.etoxproject.eu) is presented. Species, duration of exposure and administration route data were analysed to assess if large enough subsets of homogenous data are available for building in silico predictive models. Prevalence of treatment related effects for the different types of findings recorded were analysed. The eTOX ontology was used to determine the most common treatment-related clinical chemistry and histopathology findings reported in the database. The data were then mined to evaluate sensitivity of established in vivo biomarkers for liver toxicity risk assessment. The value of the database to inform other drug development projects during early drug development is illustrated by a case study., The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n°115002, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution. The authors would like to formally acknowledge the contribution to the eTOX project of all scientists and other staff involved.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A crowdsourcing workflow for extracting chemical-induced disease relations from free text.

  • Li, Tong Shu
  • Bravo Serrano, Àlex, 1984-
  • Furlong, Laura I., 1971-
  • Good, Benjamin M.
  • Su, Andrew I.
Relations between chemicals and diseases are one of the most queried biomedical interactions. Although expert manual curation is the standard method for extracting these relations from the literature, it is expensive and impractical to apply to large numbers of documents, and therefore alternative methods are required. We describe here a crowdsourcing workflow for extracting chemical-induced disease relations from free text as part of the BioCreative V Chemical Disease Relation challenge. Five non-expert workers on the CrowdFlower platform were shown each potential chemical-induced disease relation highlighted in the original source text and asked to make binary judgments about whether the text supported the relation. Worker responses were aggregated through voting, and relations receiving four or more votes were predicted as true. On the official evaluation dataset of 500 PubMed abstracts, the crowd attained a 0.505F-score (0.475 precision, 0.540 recall), with a maximum theoretical recall of 0.751 due to errors with named entity recognition. The total crowdsourcing cost was $1290.67 ($2.58 per abstract) and took a total of 7 h. A qualitative error analysis revealed that 46.66% of sampled errors were due to task limitations and gold standard errors, indicating that performance can still be improved. All code and results are publicly available athttps://github.com/SuLab/crowd_cid_relexDatabase, This work was supported by grants from the National Institutes of Health (GM114833, GM089820, TR001114); the Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (PI13/00082 and CP10/00524 to A.B. and L.I.F.); the Innovative Medicines Initiative-Joint Undertaking (eTOX No. 115002, Open PHACTs No. 115191, EMIF No. 115372, iPiE No. 115735 to A.B. and L.I.F.), resources of which are composed of financial contributions from the European Union’s Seventh Framework Programme (FP7/2007-2013) and European Federation of Pharmaceutical Industries and Associations; and the European Union Horizon 2020 Programme 2014–2020 (MedBioinformatics No. 634143 and Elixir-Excelerate No. 676559 to A.B. and L.I.F.). The Research Programme on Biomedical Informatics (GRIB) is a node of the Spanish National Institute of Bioinformatics (INB). Open access charges will be paid by grant number TR001114 from the National Institutes of Health.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

DisGeNET-RDF: harnessing the innovative power of the Semantic Web to explore the genetic basis of diseases.

  • Queralt Rosinach, Núria
  • Piñero González, Janet, 1977-
  • Bravo Serrano, Àlex, 1984-
  • Sanz, Ferran
  • Furlong, Laura I., 1971-
MOTIVATION: DisGeNET-RDF makes available knowledge on the genetic basis of human diseases in the Semantic Web. Gene-disease associations (GDAs) and their provenance metadata are published as human-readable and machine-processable web resources. The information on GDAs included in DisGeNET-RDF is interlinked to other biomedical databases to support the development of bioinformatics approaches for translational research through evidence-based exploitation of a rich and fully interconnected linked open data., We received support from ISCIII-FEDER (PI13/00082, CP10/00524), from the IMI-JU under grants agreements no. 115002 (eTOX), no. 115191 (Open PHACTS), no. 115372 (EMIF) and no. 115735 (iPiE), resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007–2013) and EFPIA companies’ in kind contribution, and the EU H2020 Programme 2014–2020 under grant agreements no. 634143 (MedBioinformatics) and no. 676559 (Elixir-Excelerate). The Research Programme on Biomedical Informatics (GRIB) is a node of the Spanish National Institute of Bioinformatics (INB).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

An automated tool for obtaining QSAR-ready series of compounds using semantic web technologies

  • López-Massaguer, Oriol
  • Sanz, Ferran
  • Pastor Maeso, Manuel
SUMMARY: We describe an application (Collector) for obtaining series of compounds annotated with bioactivity data, ready to be used for the development of quantitative structure-activity relationships (QSAR) models. The tool extracts data from the 'Open Pharmacological Space' (OPS) developed by the Open PHACTS project, using as input a valid name of the biological target. Collector uses the OPS ontologies for expanding the query using all known target synonyms and extracts compounds with bioactivity data against the target from multiple sources. The extracted data can be filtered to retain only drug-like compounds and the bioactivities can be automatically summarised to assign a single value per compound, yielding data ready to be used for QSAR modeling. The data obtained is locally stored facilitating the traceability and auditability of the process. Collector was used successfully for the development of models for toxicity endpoints within the eTOX project. AVAILABILITY AND IMPLEMENTATION: The software is available at http://phi.upf.edu/collector. The source code is located at https://github.com/phi-grib/Collector and is free for use under the GPL3 license. The web version is hosted at http://collector.upf.edu/. CONTACT: manuel.pastor@upf.edu. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online., This project was developed under the Innovative Medicines Initiative Joint Undertaking Open PHACTS Project, grant agreement number 115191 and eTOX project, grant agreement n° 115002, resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007–2013) and EFPIA companies’ in kind contributions
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Uncovering disease mechanisms through network biology in the era of next generation sequencing.

  • Piñero González, Janet, 1977-
  • Berenstein, Ariel José
  • González-Pérez, Abel
  • Chernomoretz, Ariel
  • Furlong, Laura I., 1971-
Characterizing the behavior of disease genes in the context of biological networks has the potential to shed light on disease mechanisms, and to reveal both new candidate disease genes and therapeutic targets. Previous studies addressing the network properties of disease genes have produced contradictory results. Here we have explored the causes of these discrepancies and assessed the relationship between the network roles of disease genes and their tolerance to deleterious germline variants in human populations leveraging on: the abundance of interactome resources, a comprehensive catalog of disease genes and exome variation data. We found that the most salient network features of disease genes are driven by cancer genes and that genes related to different types of diseases play network roles whose centrality is inversely correlated to their tolerance to likely deleterious germline mutations. This proved to be a multiscale signature, including global, mesoscopic and local network centrality features. Cancer driver genes, the most sensitive to deleterious variants, occupy the most central positions, followed by dominant disease genes and then by recessive disease genes, which are tolerant to variants and isolated within their network modules., We received support from UBACyT (20020130100582BA) and MinCyT (PICT2014-2701), ISCIII-FEDER (PI13/00082, CP10/00524), IMI-JU under grants agreements n° 115002 (eTOX), n° 115191 (Open PHACTS)], n° 115372 (EMIF) and n° 115735 (iPiE), resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution, and the EU H2020 Programme 2014-2020 under grant agreements no. 634143 (MedBioinformatics) and no. 676559 (Elixir-Excelerate). The Research Programme on Biomedical Informatics (GRIB) is a node of the Spanish National Institute of Bioinformatics (INB). A.G.-P. is supported by a Ramon y Cajal scholarship funded by the Spanish Ministry of Economy. The authors would like to thank the Exome Aggregation Consortium and the groups that provided exome variant data for comparison. A full list of contributing groups can be found at http://exac.broadinstitute.org/about.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

LimTox: a web tool for applied text mining of adverse event and toxicity associations of compounds, drugs and genes

  • Cañada, Andres
  • Capella-Gutierrez, Salvador
  • Rabal, Obdulia
  • Oyarzabal, Julen
  • Valencia, Alfonso
  • Krallinger, Martin
A considerable effort has been devoted to retrieve systematically information for genes and proteins as well as relationships between them. Despite the importance of chemical compounds and drugs as a central bio-entity in pharmacological and biological research, only a limited number of freely available chemical text-mining/search engine technologies are currently accessible. Here we present LimTox (Literature Mining for Toxicology), a web-based online biomedical search tool with special focus on adverse hepatobiliary reactions. It integrates a range of text mining, named entity recognition and information extraction components. LimTox relies on machine-learning, rule-based, pattern-based and term lookup strategies. This system processes scientific abstracts, a set of full text articles and medical agency assessment reports. Although the main focus of LimTox is on adverse liver events, it enables also basic searches for other organ level toxicity associations (nephrotoxicity, cardiotoxicity, thyrotoxicity and phospholipidosis). This tool supports specialized search queries for: chemical compounds/drugs, genes (with additional emphasis on key enzymes in drug metabolism, namely P450 cytochromes—CYPs) and biochemical liver markers. The LimTox website is free and open to all users and there is no login requirement. LimTox can be accessed at: http://limtox.bioinfo.cnio.es, eTOX project [IMI-115002]; European Commission H2020 project OpenMinted [654021]; Plan de Impulso de las Tecnologías del Lenguaje de la Agenda Digital (PITL) of the Secretary of State of Telecommunications of the Spanish Ministry of Energy, Tourism and the Digital Agenda; ISCIII and ERDF [PT13/0001/00]. Funding for open access charge: European Commission H2020 project Open-Minted [654021]., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes.

  • Piñero González, Janet, 1977-
  • Queralt Rosinach, Núria
  • Bravo Serrano, Àlex, 1984-
  • Déu Pons, Jordi
  • Bauer-Mehren, Anna
  • Baron, Martin
  • Sanz, Ferran
  • Furlong, Laura I., 1971-
DisGeNET is a comprehensive discovery platform designed to address a variety of questions concerning the genetic underpinning of human diseases. DisGeNET contains over 380,000 associations between >16,000 genes and 13,000 diseases, which makes it one of the largest repositories currently available of its kind. DisGeNET integrates expert-curated databases with text-mined data, covers information on Mendelian and complex diseases, and includes data from animal disease models. It features a score based on the supporting evidence to prioritize gene-disease associations. It is an open access resource available through a web interface, a Cytoscape plugin and as a Semantic Web resource. The web interface supports user-friendly data exploration and navigation. DisGeNET data can also be analysed via the DisGeNET Cytoscape plugin, and enriched with the annotations of other plugins of this popular network analysis software suite. Finally, the information contained in DisGeNET can be expanded and complemented using Semantic Web technologies and linked to a variety of resources already present in the Linked Data cloud. Hence, DisGeNET offers one of the most comprehensive collections of human gene-disease associations and a valuable set of tools for investigating the molecular mechanisms underlying diseases of genetic origin, designed to fulfill the needs of different user profiles, including bioinformaticians, biologists and health-care practitioners. Database URL: http://www.disgenet.org/, This work was supported by Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (CP10/00524 and PI13/00082), the/nInnovative Medicines Initiative Joint Undertaking (115002 (eTOX), 115191 [Open PHACTS]), resources of which are composed of financial/ncontribution from the European Union’s Seventh Framework Programme [FP7/2007-2013] and EFPIA companies’ in kind contribution./nThe Research Programme on Biomedical Informatics (GRIB) is a node of the Spanish National Institute of Bioinformatics (INB). Funding for open access charge: Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (PI13/00082).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Contribución de congreso (ConferenceOutput)

A first look into Alexa’s interaction security

  • Castell Uroz, Ismael
  • Marrugat Plaza, Xavier
  • Solé Pareta, Josep
  • Barlet Ros, Pere
With a rapidly increasing market of millions of devices, the intelligent virtual assistants (IVA) have become a new vector available to exploit security breaches. In this work we approach the third revision of the Amazon Echo ecosystem's device Alexa from a security perspective, focusing our efforts on the interaction between the user and the device. We found the client-server communications to be robust using encryption, but studying the voice message recognition system we discovered a method to execute voice commands remotely, a feature not available by default. This method could be used against the user if an attacker manages to perform a session hijacking attack on the web or mobile clients., This work was supported by the Spanish MINECO under contractTEC2017-90034-C2-1-R (ALLIANCE), Peer Reviewed, Postprint (author's final draft)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Gene-disease network analysis reveals functional modules in mendelian, complex and environmental diseases

  • Mayer, Miguel Ángel, 1960-
  • Bundschus, Markus
  • Rautschka, Michael
  • Sanz, Ferran
  • Furlong, Laura I., 1971-
Abstract/nBACKGROUND: Scientists have been trying to understand the molecular mechanisms of diseases to design preventive and therapeutic strategies for a long time. For some diseases, it has become evident that it is not enough to obtain a catalogue of the disease-related genes but to uncover how disruptions of molecular networks in the cell give rise to disease phenotypes. Moreover, with the unprecedented wealth of information available, even obtaining such catalogue is extremely difficult./n/nPRINCIPAL FINDINGS: We developed a comprehensive gene-disease association database by integrating associations from several sources that cover different biomedical aspects of diseases. In particular, we focus on the current knowledge of human genetic diseases including mendelian, complex and environmental diseases. To assess the concept of modularity of human diseases, we performed a systematic study of the emergent properties of human gene-disease networks by means of network topology and functional annotation analysis. The results indicate a highly shared genetic origin of human diseases and show that for most diseases, including mendelian, complex and environmental diseases, functional modules exist. Moreover, a core set of biological pathways is found to be associated with most human diseases. We obtained similar results when studying clusters of diseases, suggesting that related diseases might arise due to dysfunction of common biological processes in the cell./n/nCONCLUSIONS: For the first time, we include mendelian, complex and environmental diseases in an integrated gene-disease association database and show that the concept of modularity applies for all of them. We furthermore provide a functional analysis of disease-related modules providing important new biological insights, which might not be discovered when considering each of the gene-disease association repositories independently. Hence, we present a suitable framework for the study of how genetic and environmental factors, such as drugs, contribute to diseases./n/nAVAILABILITY: The gene-disease networks used in this study and part of the analysis are available at http://ibi.imim.es/DisGeNET/DisGeNETweb.html#Download, This work was supported by the European Commission [EU-ADR, ICT-215847], Innovative Medicines Initiative [eTOX,115002], the AGAUR [to A.B.M.] and Instituto de Salud Carlos III FEDER (CP10/00524) grants
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

BPC transcription factors and a Polycomb Group protein confine the expression of the ovule identity gene SEEDSTICK in Arabidopsis

  • Petrella, Rosanna
  • Caselli, Francesca
  • Roig Villanova, Irma
  • Vignati, Valentina
  • Chiara, Matteo
  • Ezquer, Ignacio
  • Tadini, Luca
  • Kater, Martin M.
  • Gregis, Veronica
The BASIC PENTACYSTEINE (BPC) GAGA (C-box) binding proteins belong to a small plant transcription factor family. We previously reported that BPCs of class I bind directly to C-boxes in the SEEDSTICK (STK) promoter and the mutagenesis of these cis-elements affects STK expression in the flower. The MADS-domain factor SHORT VEGETATIVE PHASE (SVP) is another key regulator of STK. Direct binding of SVP to CArG-boxes in the STK promoter are required to repress its expression during the first stages of flower development, Postprint (updated version)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Biana: a software framework for compiling biological interactions and analyzing networks

  • García-García, Javier, 1982-
  • Güney, Emre, 1983-
  • Aragüés Peleato, Ramón
  • Planas Iglesias, Joan, 1980-
  • Oliva Miguel, Baldomero
Background: The analysis and usage of biological data is hindered by the spread of information across multiple repositories and the difficulties posed by different nomenclature systems and storage formats. In particular, there is an important need for data unification in the study and use of protein-protein interactions. Without good integration strategies, it is difficult to analyze the whole set of available data and its properties./nResults: We introduce BIANA (Biologic Interactions and Network Analysis), a tool for biological information integration and network management. BIANA is a Python framework designed to achieve two major goals: i) the integration of multiple sources of biological information, including biological entities and their relationships, and ii) the management of biological information as a network where entities are nodes and relationships are edges. Moreover, BIANA uses properties of proteins and genes to infer latent biomolecular relationships by transferring edges to entities sharing similar properties. BIANA is also provided as a plugin for Cytoscape, which allows users to visualize and interactively manage the data. A web interface to BIANA providing basic functionalities is also available. The software can be downloaded under GNU GPL license from http://sbi.imim.es/web/BIANA.php./nConclusions: BIANA's approach to data unification solves many of the nomenclature issues common to systems dealing with biological data. BIANA can easily be extended to handle new specific data repositories and new specific data types. The unification protocol allows BIANA to be a flexible tool suitable for different user requirements: non-expert users can use a suggested unification protocol while expert users can define their own specific unification rules., JGG, EG and JPI are grateful to the support from “Departament d’Educació i Universitats de la Generalitat de Catalunya i del Fons Social Europeu”. BO also acknowledges support from BSC and Mare-Nostrum facilities. This work was supported by grants from Spanish Ministry of Science and Innovation (MICINN) BIO2008-0205, PSE-0100000-2007 and PSE-0100000-2009, and from EU grant Etox (IMI 115002)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

In Silico QT and APD prolongation assay for early screening of drug-induced proarrhythmic risk

  • Romero, Lucia
  • Cano, Jordi
  • Gomis-Tena, Julio
  • Trenor, Beatriz
  • Sanz, Ferran
  • Pastor Maeso, Manuel
  • Saiz, Javier
Drug-induced proarrhythmicity is a major concern for regulators and pharmaceutical companies. For novel drug candidates, the standard assessment involves the evaluation of the potassium hERG channels block and the in vivo prolongation of the QT interval. However, this method is known to be too restrictive and to stop the development of potentially valuable therapeutic drugs. The aim of this work is to create an in silico tool for early detection of drug-induced proarrhythmic risk. The system is based on simulations of how different compounds affect the action potential duration (APD) of isolated endocardial, midmyocardial, and epicardial cells as well as the QT prolongation in a virtual tissue. Multiple channel-drug interactions and state-of-the-art human ventricular action potential models ( O'Hara , T. , PLos Comput. Biol. 2011 , 7 , e1002061 ) were used in our simulations. Specifically, 206.766 cellular and 7072 tissue simulations were performed by blocking the slow and the fast components of the delayed rectifier current ( IKs and IKr, respectively) and the L-type calcium current ( ICaL) at different levels. The performance of our system was validated by classifying the proarrhythmic risk of 84 compounds, 40 of which present torsadogenic properties. On the basis of these results, we propose the use of a new index (Tx) for discriminating torsadogenic compounds, defined as the ratio of the drug concentrations producing 10% prolongation of the cellular endocardial, midmyocardial, and epicardial APDs and the QT interval, over the maximum effective free therapeutic plasma concentration (EFTPC). Our results show that the Tx index outperforms standard methods for early identification of torsadogenic compounds. Indeed, for the analyzed compounds, the Tx tests accuracy was in the range of 87-88% compared with a 73% accuracy of the hERG IC50 based test., L.R., J.C., J.G., B.T., J.S.: This work was partially supported by the Direccion General de Política Cientifíca de la Generalitat Valenciana (PROMETEU2016/088) as well as Ministerio de Economia y Competitividad and Fondo Europeo de Desarrollo Regional (FEDER) DPI2015-69125-R (MINECO/FEDER, UE). F.S, M.P.: received support from the Innovative Medicines Initiative (IMI) Joint Undertaking under grant agreement no. 115002 (eTOX), resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in-kind contributions
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Mining the modular structure of protein interaction networks.

  • Berenstein, Ariel José
  • Piñero González, Janet, 1977-
  • Furlong, Laura I., 1971-
  • Chernomoretz, Ariel
BACKGROUND: Cluster-based descriptions of biological networks have received much attention in recent years fostered by accumulated evidence of the existence of meaningful correlations between topological network clusters and biological functional modules. Several well-performing clustering algorithms exist to infer topological network partitions. However, due to respective technical idiosyncrasies they might produce dissimilar modular decompositions of a given network. In this contribution, we aimed to analyze how alternative modular descriptions could condition the outcome of follow-up network biology analysis. METHODOLOGY: We considered a human protein interaction network and two paradigmatic cluster recognition algorithms, namely: the Clauset-Newman-Moore and the infomap procedures. We analyzed to what extent both methodologies yielded different results in terms of granularity and biological congruency. In addition, taking into account Guimera's cartographic role characterization of network nodes, we explored how the adoption of a given clustering methodology impinged on the ability to highlight relevant network meso-scale connectivity patterns. RESULTS: As a case study we considered a set of aging related proteins and showed that only the high-resolution modular description provided by infomap, could unveil statistically significant associations between them and inter/intra modular cartographic features. Besides reporting novel biological insights that could be gained from the discovered associations, our contribution warns against possible technical concerns that might affect the tools used to mine for interaction patterns in network biology studies. In particular our results suggested that sub-optimal partitions from the strict point of view of their modularity levels might still be worth being analyzed when meso-scale features were to be explored in connection with external source of biological knowledge., This project has been made possible by CONICET (grant PIP0087), UBACyT (grant 20020110200314), ISCIII-FEDER (PI13/00082 and CP10/00524), IMI JU (grant agreements n° [115002] (eTOX) and n° [115191] (Open PHACTS)], resources of which are composed of financial contribution from the EU's FP7 (FP7/2007–2013) and EFPIA companies’ in kind contribution)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

eTOXlab, an open source modeling framework for implementing predictive models in production environments.

  • Carrió Gaspar, Pau, 1982-
  • López, Oriol
  • Sanz, Ferran
  • Pastor Maeso, Manuel
BACKGROUND: Computational models based in Quantitative-Structure Activity Relationship (QSAR) methodologies are widely used tools for predicting the biological properties of new compounds. In many instances, such models are used as a routine in the industry (e.g. food, cosmetic or pharmaceutical industry) for the early assessment of the biological properties of new compounds. However, most of the tools currently available for developing QSAR models are not well suited for supporting the whole QSAR model life cycle in production environments./nRESULTS: We have developed eTOXlab; an open source modeling framework designed to be used at the core of a self-contained virtual machine that can be easily deployed in production environments, providing predictions as web services. eTOXlab consists on a collection of object-oriented Python modules with methods mapping common tasks of standard modeling workflows. This framework allows building and validating QSAR models as well as predicting the properties of new compounds using either a command line interface or a graphic user interface (GUI). Simple models can be easily generated by setting a few parameters, while more complex models can be implemented by overriding pieces of the original source code. eTOXlab benefits from the object-oriented capabilities of Python for providing high flexibility: any model implemented using eTOXlab inherits the features implemented in the parent model, like common tools and services or the automatic exposure of the models as prediction web services. The particular eTOXlab architecture as a self-contained, portable prediction engine allows building models with confidential information within corporate facilities, which can be safely exported and used for prediction without disclosing the structures of the training series. CONCLUSIONS: The software presented here provides full support to the specific needs of users that want to develop, use and maintain predictive models in corporate environments. The technologies used by eTOXlab (web services, VM, object-oriented programming) provide an elegant solution to common practical issues; the system can be installed easily in heterogeneous environments and integrates well with other software. Moreover, the system provides a simple and safe solution for building models with confidential structures that can be shared without disclosing sensitive information, The research leading to these results has received support from the Innovative Medicines Initiative (IMI) Joint Undertaking under grant agreement n° 115002 (eTOX), resources of which are composed of financial contribution from the/nEuropean Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contributions
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Hepatotoxicity prediction by systems biology modeling of disturbed metabolic pathways using gene expression data

  • Carbonell, Pablo
  • López, Oriol
  • Amberg, Alexander
  • Pastor Maeso, Manuel
  • Sanz, Ferran
The present study applies a systems biology approach for the in silico predictive modeling of drug toxicity on the basis of high-quality preclinical drug toxicity data with the aim of increasing the mechanistic understanding of toxic effects of compounds at different levels (pathway, cell, tissue, organ). The model development was carried out using 77 compounds for which gene expression data for treated primary human hepatocytes is available in the LINCS database and for which rodent in vivo hepatotoxicity information is available in the eTOX database. The data from LINCS were used to determine the type and number of pathways disturbed by each compound and to estimate the extent of disturbance (network perturbation elasticity), and were used to analyze the correspondence with the in vivo information from eTOX. Predictive models were developed through this integrative analysis, and their specificity and sensitivity were assessed. The quality of the predictions was determined on the basis of the area under the curve (AUC) of plots of true positive vs. false positive rates (ROC curves). The ROC AUC reached values of up to 0.9 (out of 1.0) for some hepatotoxicity endpoints. Moreover, the most frequently disturbed metabolic pathways were determined across the studied toxicants. They included, e.g., mitochondrial beta-oxidation of fatty acids and amino acid metabolism. The process was exemplified by successful predictions on various statins. In conclusion, an entirely new approach linking gene expression alterations to the prediction of complex organ toxicity was developed and evaluated., The research leading to these results has received support from the Innovative Medicines Initiative (IMI) Joint Undertaking under grant agreement nº 115002 (eTOX), resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/200-2013) and EFPIA companie's in kind contributions.
Archivo Digital UPM
Publicación Artículo científico (JournalArticle)

Improving data and knowledge management to better integrate health care and research

  • Cases, M.
  • Furlong, L. I.
  • Albanell, J.
  • Altman, R. B.
  • Bellazzi, Riccardo|||0000-0002-6974-9808
  • Boyer, S.
  • Brand, A.
  • Brookes, A. J.
  • Brunak, S.
  • Clark, T. W.
  • Gea, J.
  • Ghazal, Peter
  • Graf, Norbert
  • Guigó, R.
  • Klein, T. E.
  • López-Bigas, N.
  • Maojo García, Víctor Manuel|||0000-0001-5103-4292
  • Mons, B.
  • Musen, M.
  • Oliveira, José Luís
  • Rowe, A.
  • Ruch, P.
  • Shabo, A.
  • Shortliffe, E. H.
  • Valencia, A.
  • Lei, J. van der
  • Mayer Pujadas, Miguel A.
  • Sanz Carreras, Ferrán